Numenos Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $7.7M

  • Investors
  • 3

Numenos General Information

Description

Developer of biological world models designed to uncover fundamental biological principles and support drug development. The company offers novel artificial intelligence architectures for modeling biological systems and evaluating drug candidates, enabling pharmaceutical and biotechnology companies to improve drug development and make clinical testing more focused on confirming expected outcomes.

Contact Information

Website
www.numenos.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Canal Street
  • New York, NY
  • United States
Primary Industry
Other Healthcare Technology Systems
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • Canal Street
  • New York, NY
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Numenos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 21-Jan-2025 $7.7M Completed Generating Revenue
To view Numenos’s complete valuation and funding history, request access »

Numenos Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-2
Seed-1
To view Numenos’s complete cap table history, request access »

Numenos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Numenos Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dhuna Ventures Venture Capital Minority
Meron Capital Venture Capital Minority
TechAviv Founder Partners Venture Capital Minority
To view Numenos’s complete investors history, request access »

Ready to get started?

Request a free trial

Numenos FAQs

  • When was Numenos founded?

    Numenos was founded in 2023.

  • Where is Numenos headquartered?

    Numenos is headquartered in New York, NY.

  • What is the size of Numenos?

    Numenos has 14 total employees.

  • What industry is Numenos in?

    Numenos’s primary industry is Other Healthcare Technology Systems.

  • Is Numenos a private or public company?

    Numenos is a Private company.

  • What is the current valuation of Numenos?

    The current valuation of Numenos is .

  • What is Numenos’s current revenue?

    The current revenue for Numenos is .

  • How much funding has Numenos raised over time?

    Numenos has raised $7.7M.

  • Who are Numenos’s investors?

    Dhuna Ventures, Meron Capital, and TechAviv Founder Partners have invested in Numenos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process